Acciones Hartford Great Health Corp. Other OTC
Acciones
HFUS
US41653H1068
Publicidad y marketing
Ventas 2022 | 0,56 0,52 | Ventas 2023 | - | Capitalización | 88,1 M 81,52 M |
---|---|---|---|---|---|
Resultado Neto 2022 | -1 M -925 mil | Resultado Neto 2023 | - 0 | VE / Ventas 2022 | 28.314.089 x |
Deuda neta 2022 | 275 mil 254 mil | Deuda neta 2023 | 412 mil 381 mil | VE / Ventas 2023 | - |
P/E ratio 2022 |
-9,89
x | P/E ratio 2023 |
222
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 16,32 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Sheng-Yih Chang
CEO | Chief Executive Officer | 53 | 11/06/18 |
Hong Wang
PSD | President | 52 | 13/09/21 |
Xin Dong
BRD | Director/Board Member | 40 | 11/06/18 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Xin Dong
BRD | Director/Board Member | 40 | 11/06/18 |
Sheng-Yih Chang
CEO | Chief Executive Officer | 53 | 11/06/18 |
Yuan Lu
BRD | Director/Board Member | 39 | 01/01/19 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+13,05 % | 6860,57 M | |
-33,77 % | 1419,83 M | |
-9,37 % | 1185,83 M | |
-22,56 % | 975 M | |
-4,83 % | 538 M | |
+25,19 % | 471 M | |
+15,34 % | 464 M | |
-41,32 % | 411 M | |
-39,25 % | 325 M |